NPPB and cardiac hypertrophy: Furthermore, expression of BNP, a marker of cardiac hypertrophy [15,16], was also elevated in the heart of animals exposed to regorafenib (+33%, p < 0.001) and sorafenib (+25%), although in the latter case the difference did not reach statistical significance (Figure S2).